{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:56:10Z","timestamp":1792403770026,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Long non-coding RNAs (lncRNAs) can crosstalk with each other by post-transcriptionally co-regulating genes involved in the same or similar functions; however, the regulatory principles and biological insights in tumor-immune are still unclear. Here, we show a multiple-step model to identify lncRNA-lncRNA immune cooperation based on co-regulating functional modules by integrating multi-omics data across 20 cancer types. Moreover, lncRNA immune cooperative networks (LICNs) are constructed, which are likely to modulate tumor-immune microenvironment by regulating immune-related functions. We highlight conserved and rewired network hubs which can regulate interactions between immune cells and tumor cells by targeting ligands and activating or inhibitory receptors such as\n                    <jats:italic>PDCD1<\/jats:italic>\n                    ,\n                    <jats:italic>CTLA4<\/jats:italic>\n                    and\n                    <jats:italic>CD86<\/jats:italic>\n                    . Immune cooperative lncRNAs (IC-lncRNAs) playing central roles in many cancers also tend to target known anticancer drug targets. In addition, these IC-lncRNAs tend to be highly expressed in immune cell populations and are significantly correlated with immune cell infiltration. The similar immune mechanisms cross cancers are revealed by the LICNs. Finally, we identify two subtypes of skin cutaneous melanoma with different immune context and prognosis based on IC-lncRNAs. In summary, this study contributes to a comprehensive understanding of the cooperative behaviours of lncRNAs and accelerating discovery of lncRNA-based biomarkers in cancer.\n                  <\/jats:p>","DOI":"10.1038\/s42003-022-04249-0","type":"journal-article","created":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:11:03Z","timestamp":1670026263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Surveying lncRNA-lncRNA cooperations reveals dominant effect on tumor immunity cross cancers"],"prefix":"10.1038","volume":"5","author":[{"given":"Tingting","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhe","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3709-4165","authenticated-orcid":false,"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-2648","authenticated-orcid":false,"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,3]]},"reference":[{"key":"4249_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nrm.2016.126","volume":"17","author":"JM Engreitz","year":"2016","unstructured":"Engreitz, J. M., Ollikainen, N. & Guttman, M. Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression. Nat. Rev. Mol. Cell Biol. 17, 756\u2013770 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"4249_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41580-019-0209-0","volume":"21","author":"L Nair","year":"2020","unstructured":"Nair, L., Chung, H. & Basu, U. Regulation of long non-coding RNAs and genome dynamics by the RNA surveillance machinery. Nat. Rev. Mol. Cell Biol. 21, 123\u2013136 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"4249_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt, A. M. & Chang, H. Y. Long noncoding RNAs in cancer pathways. Cancer Cell 29, 452\u2013463 (2016).","journal-title":"Cancer Cell"},{"key":"4249_CR4","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1002\/jcp.26568","volume":"233","author":"WD Yu","year":"2018","unstructured":"Yu, W. D., Wang, H., He, Q. F., Xu, Y. & Wang, X. C. Long noncoding RNAs in cancer-immunity cycle. J. Cell Physiol. 233, 6518\u20136523 (2018).","journal-title":"J. Cell Physiol."},{"key":"4249_CR5","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1002\/jcb.29621","volume":"121","author":"RS DeVaux","year":"2020","unstructured":"DeVaux, R. S. et al. Long noncoding RNA BHLHE40-AS1 promotes early breast cancer progression through modulating IL-6\/STAT3 signaling. J. Cell Biochem. 121, 3465\u20133478 (2020).","journal-title":"J. Cell Biochem."},{"key":"4249_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14802-2","volume":"11","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers. Nat. Commun. 11, 1000 (2020).","journal-title":"Nat. Commun."},{"key":"4249_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1158\/2326-6066.CIR-19-0696","volume":"8","author":"S Xu","year":"2020","unstructured":"Xu, S. et al. Long noncoding RNAs control the modulation of immune checkpoint molecules in cancer. Cancer Immunol. Res. 8, 937\u2013951 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"4249_CR8","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1093\/bib\/bby038","volume":"20","author":"T Shao","year":"2019","unstructured":"Shao, T. et al. Survey of miRNA-miRNA cooperative regulation principles across cancer types. Brief. Bioinform. 20, 1621\u20131638 (2019).","journal-title":"Brief. Bioinform."},{"key":"4249_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.celrep.2018.03.064","volume":"23","author":"HS Chiu","year":"2018","unstructured":"Chiu, H. S. et al. Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes in each tumor context. Cell Rep. 23, 297\u2013312.e212 (2018).","journal-title":"Cell Rep."},{"key":"4249_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep36045","volume":"6","author":"M Wu","year":"2016","unstructured":"Wu, M. et al. HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2. Sci. Rep. 6, 36045 (2016).","journal-title":"Sci. Rep."},{"key":"4249_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03179-5","volume":"19","author":"H Zhou","year":"2021","unstructured":"Zhou, H. et al. Identifying and characterizing lincRNA genomic clusters reveals its cooperative functions in human cancer. J. Transl. Med. 19, 509 (2021).","journal-title":"J. Transl. Med."},{"key":"4249_CR12","doi-asserted-by":"publisher","first-page":"eaat6912","DOI":"10.1126\/scitranslmed.aat6912","volume":"10","author":"Q Meng","year":"2018","unstructured":"Meng, Q. et al. The DGCR5 long noncoding RNA may regulate expression of several schizophrenia-related genes. Sci. Transl. Med. 10, eaat6912 (2018).","journal-title":"Sci. Transl. Med."},{"key":"4249_CR13","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkx232","volume":"45","author":"J Zhou","year":"2017","unstructured":"Zhou, J., Zhang, S., Wang, H. & Sun, H. LncFunNet: an integrated computational framework for identification of functional long noncoding RNAs in mouse skeletal muscle cells. Nucleic Acids Res. 45, e108 (2017).","journal-title":"Nucleic Acids Res."},{"key":"4249_CR14","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1158\/0008-5472.CAN-18-0529","volume":"78","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Integrative genome-wide analysis of long noncoding RNAs in diverse immune cell types of melanoma patients. Cancer Res. 78, 4411\u20134423 (2018).","journal-title":"Cancer Res."},{"key":"4249_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cmet.2016.11.016","volume":"25","author":"I Akerman","year":"2017","unstructured":"Akerman, I. et al. Human pancreatic \u03b2 cell lncRNAs control cell-specific regulatory networks. Cell Metab. 25, 400\u2013411 (2017).","journal-title":"Cell Metab."},{"key":"4249_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ymthe.2019.01.001","volume":"27","author":"KP Zhu","year":"2019","unstructured":"Zhu, K. P. et al. Analyzing the interactions of mRNAs and ncRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance. Mol. Ther. 27, 518\u2013530 (2019).","journal-title":"Mol. Ther."},{"key":"4249_CR17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/nar\/gkq832","volume":"39","author":"J Xu","year":"2011","unstructured":"Xu, J. et al. MiRNA-miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features. Nucleic Acids Res. 39, 825\u2013836 (2011).","journal-title":"Nucleic Acids Res."},{"key":"4249_CR18","first-page":"72","volume":"35","author":"F Li","year":"2020","unstructured":"Li, F., Hu, Q., Pang, Z. & Xu, X. LncRNA MAGI2-AS3 upregulates cytokine signaling 1 by sponging mir-155 in non-small cell lung cancer. Cancer Biother. Radiopharm. 35, 72\u201376 (2020).","journal-title":"Cancer Biother. Radiopharm."},{"key":"4249_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrclinonc.2015.209","volume":"13","author":"MJ Smyth","year":"2016","unstructured":"Smyth, M. J., Ngiow, S. F., Ribas, A. & Teng, M. W. Combination cancer immunotherapies tailored to the tumour microenvironment. Nat. Rev. Clin. Oncol. 13, 143\u2013158 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"4249_CR20","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1096\/fj.201902705RR","volume":"34","author":"J Gao","year":"2020","unstructured":"Gao, J., Dai, C., Yu, X., Yin, X. B. & Zhou, F. Long noncoding RNA LINC00324 exerts protumorigenic effects on liver cancer stem cells by upregulating fas ligand via PU box binding protein. FASEB J. 34, 5800\u20135817 (2020).","journal-title":"FASEB J."},{"key":"4249_CR21","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.drudis.2017.05.016","volume":"22","author":"MG Dal Bello","year":"2017","unstructured":"Dal Bello, M. G., Alama, A., Coco, S., Vanni, I. & Grossi, F. Understanding the checkpoint blockade in lung cancer immunotherapy. Drug Discov. Today 22, 1266\u20131273 (2017).","journal-title":"Drug Discov. Today"},{"key":"4249_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","volume":"176","author":"H Li","year":"2019","unstructured":"Li, H. et al. Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell 176, 775\u2013789.e718 (2019).","journal-title":"Cell"},{"key":"4249_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-3444-7","volume":"21","author":"HC Chang","year":"2020","unstructured":"Chang, H. C., Chu, C. P., Lin, S. J. & Hsiao, C. K. Network hub-node prioritization of gene regulation with intra-network association. BMC Bioinformatics 21, 101 (2020).","journal-title":"BMC Bioinformatics"},{"key":"4249_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrg1272","volume":"5","author":"AL Barabasi","year":"2004","unstructured":"Barabasi, A. L. & Oltvai, Z. N. Network biology: understanding the cell\u2019s functional organization. Nat. Rev. Genet. 5, 101\u2013113 (2004).","journal-title":"Nat. Rev. Genet."},{"key":"4249_CR25","doi-asserted-by":"publisher","first-page":"101042831770164","DOI":"10.1177\/1010428317701648","volume":"39","author":"E Baytak","year":"2017","unstructured":"Baytak, E. et al. Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer\/T-cell lymphoma and establishes MIR155HG as a target of PRDM1. Tumour Biol. 39, 1010428317701648 (2017).","journal-title":"Tumour Biol."},{"key":"4249_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","volume":"14","author":"M Mohme","year":"2017","unstructured":"Mohme, M., Riethdorf, S. & Pantel, K. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape. Nat. Rev. Clin. Oncol. 14, 155\u2013167 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"4249_CR27","first-page":"5968","volume":"18","author":"J Peng","year":"2019","unstructured":"Peng, J. et al. Silencing of KCNK15-AS1 inhibits lung cancer cell proliferation via upregulation of miR-202 and miR-370. Oncol. Lett. 18, 5968\u20135976 (2019).","journal-title":"Oncol. Lett."},{"key":"4249_CR28","doi-asserted-by":"publisher","first-page":"8589","DOI":"10.2147\/CMAR.S186002","volume":"11","author":"H Zhang","year":"2019","unstructured":"Zhang, H., Zhang, Z. & Wang, D. Epigenetic regulation of IncRNA KCNKI5-ASI in gastric cancer. Cancer Manag Res. 11, 8589\u20138602 (2019).","journal-title":"Cancer Manag Res."},{"key":"4249_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541\u2013550 (2018).","journal-title":"Nat. Med."},{"key":"4249_CR30","doi-asserted-by":"publisher","first-page":"963689720906777","DOI":"10.1177\/0963689720906777","volume":"29","author":"Z Yao","year":"2020","unstructured":"Yao, Z. et al. Long noncoding RNA PCED1B-AS1 promotes the warburg effect and tumorigenesis by upregulating HIF-1alpha in glioblastoma. Cell Transplant. 29, 963689720906777 (2020).","journal-title":"Cell Transplant."},{"key":"4249_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41419-018-0758-8","volume":"9","author":"Z Zou","year":"2018","unstructured":"Zou, Z. et al. Long intergenic non-coding RNA 00324 promotes gastric cancer cell proliferation via binding with HuR and stabilizing FAM83B expression. Cell Death Dis. 9, 717 (2018).","journal-title":"Cell Death Dis."},{"key":"4249_CR32","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4191","volume":"22","author":"RJ Hause","year":"2016","unstructured":"Hause, R. J., Pritchard, C. C., Shendure, J. & Salipante, S. J. Classification and characterization of microsatellite instability across 18 cancer types. Nat. Med. 22, 1342\u20131350 (2016).","journal-title":"Nat. Med."},{"key":"4249_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291\u2013304.e296 (2018).","journal-title":"Cell"},{"key":"4249_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nm.3984","volume":"22","author":"N Andor","year":"2016","unstructured":"Andor, N. et al. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. Nat. Med. 22, 105\u2013113 (2016).","journal-title":"Nat. Med."},{"key":"4249_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2015.11.009","volume":"39","author":"E Becht","year":"2016","unstructured":"Becht, E., Giraldo, N. A., Dieu-Nosjean, M. C., Sautes-Fridman, C. & Fridman, W. H. Cancer immune contexture and immunotherapy. Curr. Opin. Immunol. 39, 7\u201313 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"4249_CR36","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41591-018-0040-8","volume":"24","author":"N Zacharakis","year":"2018","unstructured":"Zacharakis, N. et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat. Med. 24, 724\u2013730 (2018).","journal-title":"Nat. Med."},{"key":"4249_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.immuni.2019.12.018","volume":"52","author":"J Galon","year":"2020","unstructured":"Galon, J. & Bruni, D. Tumor immunology and tumor evolution: intertwined histories. Immunity 52, 55\u201381 (2020).","journal-title":"Immunity"},{"key":"4249_CR38","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1002\/cam4.2583","volume":"8","author":"L Peng","year":"2019","unstructured":"Peng, L., Chen, Z., Chen, Y., Wang, X. & Tang, N. MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers. Cancer Med. 8, 7161\u20137173 (2019).","journal-title":"Cancer Med."},{"key":"4249_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40257-017-0325-6","volume":"19","author":"EA Rozeman","year":"2018","unstructured":"Rozeman, E. A., Dekker, T. J. A., Haanen, J. & Blank, C. U. Advanced melanoma: current treatment options, biomarkers, and future perspectives. Am. J. Clin. Dermatol. 19, 303\u2013317 (2018).","journal-title":"Am. J. Clin. Dermatol."},{"key":"4249_CR40","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3389\/fimmu.2017.01594","volume":"8","author":"KM Hargadon","year":"2017","unstructured":"Hargadon, K. M. Strategies to improve the efficacy of dendritic cell-based immunotherapy for melanoma. Front. Immunol. 8, 1594 (2017).","journal-title":"Front. Immunol."},{"key":"4249_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48\u201361 (2015).","journal-title":"Cell"},{"key":"4249_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01460-0","volume":"8","author":"M Lauss","year":"2017","unstructured":"Lauss, M. et al. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nat. Commun. 8, 1738 (2017).","journal-title":"Nat. Commun."},{"key":"4249_CR43","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/annonc\/mdz182","volume":"30","author":"P Lorigan","year":"2019","unstructured":"Lorigan, P. & Eggermont, A. M. M. Anti-PD1 treatment of advanced melanoma: development of criteria for a safe stop. Ann. Oncol. 30, 1038\u20131040 (2019).","journal-title":"Ann. Oncol."},{"key":"4249_CR44","doi-asserted-by":"publisher","first-page":"16445","DOI":"10.18632\/aging.203166","volume":"13","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia. Aging 13, 16445\u201316470 (2021).","journal-title":"Aging"},{"key":"4249_CR45","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1158\/2159-8290.CD-19-0499","volume":"9","author":"L Vuong","year":"2019","unstructured":"Vuong, L., Kotecha, R. R., Voss, M. H. & Hakimi, A. A. Tumor microenvironment dynamics in clear-cell renal cell carcinoma. Cancer Discov. 9, 1349\u20131357 (2019).","journal-title":"Cancer Discov."},{"key":"4249_CR46","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00262-019-02327-7","volume":"68","author":"CN Baxevanis","year":"2019","unstructured":"Baxevanis, C. N., Sofopoulos, M., Fortis, S. P. & Perez, S. A. The role of immune infiltrates as prognostic biomarkers in patients with breast cancer. Cancer Immunol. Immunother. 68, 1671\u20131680 (2019).","journal-title":"Cancer Immunol. Immunother."},{"key":"4249_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/CCID.S158043","volume":"11","author":"HR Ghasemi Basir","year":"2018","unstructured":"Ghasemi Basir, H. R., Alirezaei, P., Ahovan, S. & Moradi, A. The relationship between mitotic rate and depth of invasion in biopsies of malignant melanoma. Clin. Cosmet. Investig. Dermatol. 11, 125\u2013130 (2018).","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"4249_CR48","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","volume":"9","author":"KD Brantsch","year":"2008","unstructured":"Brantsch, K. D. et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 9, 713\u2013720 (2008).","journal-title":"Lancet Oncol."},{"key":"4249_CR49","doi-asserted-by":"publisher","first-page":"446e","DOI":"10.1097\/PRS.0b013e31829ad411","volume":"132","author":"WW Dzwierzynski","year":"2013","unstructured":"Dzwierzynski, W. W. Managing malignant melanoma. Plast. Reconstr. Surg. 132, 446e\u2013460e (2013).","journal-title":"Plast. Reconstr. Surg."},{"key":"4249_CR50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.canlet.2016.09.003","volume":"382","author":"S Jiang","year":"2016","unstructured":"Jiang, S. & Yan, W. T-cell immunometabolism against cancer. Cancer Lett. 382, 255\u2013258 (2016).","journal-title":"Cancer Lett."},{"key":"4249_CR51","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"Borst, J., Ahrends, T., Babala, N., Melief, C. J. M. & Kastenmuller, W. CD4(+) T cell help in cancer immunology and immunotherapy. Nat. Rev. Immunol. 18, 635\u2013647 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"4249_CR52","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrd4591","volume":"14","author":"KM Mahoney","year":"2015","unstructured":"Mahoney, K. M., Rennert, P. D. & Freeman, G. J. Combination cancer immunotherapy and new immunomodulatory targets. Nat. Rev. Drug Discov. 14, 561\u2013584 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"4249_CR53","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"N Cancer Genome Atlas Research","year":"2013","unstructured":"Cancer Genome Atlas Research, N. et al. The Cancer Genome Atlas pan-cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"4249_CR54","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1158\/0008-5472.CAN-15-0273","volume":"75","author":"J Li","year":"2015","unstructured":"Li, J. et al. TANRIC: an interactive open platform to explore the function of lncRNAs in cancer. Cancer Res. 75, 3728\u20133737 (2015).","journal-title":"Cancer Res."},{"key":"4249_CR55","unstructured":"Broad Institute TCGA Genome Data Analysis Center (2015): Firehose stddata__2015_04_02 run. Broad Institute of MIT and Harvard."},{"key":"4249_CR56","doi-asserted-by":"publisher","first-page":"25003","DOI":"10.18632\/oncotarget.4660","volume":"6","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer. Oncotarget 6, 25003\u201325016 (2015).","journal-title":"Oncotarget"},{"key":"4249_CR57","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77, e108\u2013e110 (2017).","journal-title":"Cancer Res."},{"key":"4249_CR58","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04249-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04249-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04249-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T09:42:44Z","timestamp":1670233364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04249-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,3]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4249"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-04249-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1624913\/v1","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,3]]},"assertion":[{"value":"5 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1324"}}